Do-it-Yourself Manufacturing

Richard WebbyCourtesy of St. Jude Children's Research HospitalWhen Richard Webby heard through the grapevine that his employer, St. Jude Children's Research Hospital in Memphis, Tenn., planned to build a factory on the hospital campus, he didn't express much interest, assuming it was a business decision. "It was a shrug your shoulders kind of reaction," says the virologist who is part of the World Health Organization's network of influenza experts.But when the Asian bird flu erupted in 2003, he

Written bySam Jaffe
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of St. Jude Children's Research Hospital

When Richard Webby heard through the grapevine that his employer, St. Jude Children's Research Hospital in Memphis, Tenn., planned to build a factory on the hospital campus, he didn't express much interest, assuming it was a business decision. "It was a shrug your shoulders kind of reaction," says the virologist who is part of the World Health Organization's network of influenza experts.

But when the Asian bird flu erupted in 2003, he quickly acquainted himself with the new facility. Webby and his research team raced against the clock to produce seed strains of the new flu for a vaccine in case the disease jumped to humans. To meet Food and Drug Administration vaccine standards, he needed great quantities of the virus and all samples had to go through a rigorous quality-control process. His own biology lab wasn't equipped to do that. So he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies